SELLAS Life Sciences Group, Inc.
(NASDAQ : SLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.25%175.490.7%$1348.91m
MRKMerck & Co., Inc. -1.44%91.090.7%$1211.42m
PFEPfizer Inc. -3.20%50.640.9%$1081.72m
LLYEli Lilly & Co. -1.19%320.851.1%$1023.75m
BMYBristol-Myers Squibb Co. -2.40%75.001.0%$981.18m
ABBVAbbVie, Inc. -2.11%150.551.9%$950.23m
AZNAstraZeneca Plc -1.87%64.721.0%$458.04m
SGENSeagen Inc. -2.89%174.915.7%$328.36m
GSKGSK Plc -2.22%42.780.2%$272.62m
TPTXTurning Point Therapeutics, Inc. 0.07%75.170.0%$203.00m
HZNPHorizon Therapeutics Plc 2.01%82.475.4%$174.03m
NVSNovartis AG -1.09%83.440.2%$170.72m
MRTXMirati Therapeutics, Inc. -2.60%69.331.6%$148.80m
ALNYAlnylam Pharmaceuticals, Inc. -0.52%147.488.1%$148.60m
NVONovo Nordisk A/S -2.02%109.390.1%$139.08m

Company Profile

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.